Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01070368
Other study ID # 231/2552(EC4)
Secondary ID
Status Completed
Phase N/A
First received February 16, 2010
Last updated February 27, 2013
Start date June 2009
Est. completion date October 2012

Study information

Verified date February 2013
Source Mahidol University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Nowadays, commercial wheat extract is widely accessible, and is used for skin prick test for wheat allergy. However, commercial wheat extracted for skin prick test have less precise test result compared to extract from omega-5 gliadin, which is one of the major allergen with immediate wheat allergy.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date October 2012
Est. primary completion date October 2012
Accepts healthy volunteers No
Gender All
Age group 1 Year to 15 Years
Eligibility Inclusion Criteria:

- A patient with the age of 1-15 year old

- A history of symptoms that suspected of type 1 hypersensitivity (eg. Urticaria, angioedema, wheezing, anaphylaxis) occur within 4 hours after wheat ingestion.

- Patients attend in allergy clinic, pediatric department, Siriraj hospital since 2007-2012

Exclusion Criteria:

- First sign and symptom happens more than 4 hours since wheat ingestion

- Have underlying disease such as heart disease, epilepsy etc.

- Have contraindication for performed skin prick test

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Commercial extract and in-house wheat extract
Patients with a history of wheat allergy underwent two skin test extracts, and open challenge with wheat. A blood test for specific IgE was performed in the same time.

Locations

Country Name City State
Thailand Pediatric department, Faculty of medicine Siriraj hospital, Mahidol university Bangkok

Sponsors (1)

Lead Sponsor Collaborator
Mahidol University

Country where clinical trial is conducted

Thailand, 

Outcome

Type Measure Description Time frame Safety issue
Primary correlation skin test result and food challenge result 3 year
Secondary comparison of skin test result and specific IgE to challenge result 3 year
See also
  Status Clinical Trial Phase
Completed NCT04100122 - Luminex-based Assay to Identify Major IgE-binding Episode Among IgE-mediated Wheat-allergic Patient
Completed NCT01980992 - Oral Immunotherapy for Wheat Allergy Phase 1/Phase 2
Terminated NCT02341040 - Evaluation of Potential Allergenicity of New Wheat Varieties
Completed NCT01801748 - The Natural History of Wheat Hypersensitivity in Thai Children N/A
Recruiting NCT06069492 - Randomized Controlled Trial for Wheat Oral Immunotherapy N/A
Terminated NCT04013763 - Outcome of Specific IgE Level in Children With IgE-mediated Wheat Allergy After Stop Using Wheat Containing Skin Care N/A
Recruiting NCT03352193 - Specific Oral Tolerance Induction (SOTI) to Children With IgE-mediated Wheat Allergy
Completed NCT01755884 - Oral Desensitization to Wheat in School Aged Children N/A
Completed NCT03487315 - Major Allergen in Wheat Anaphylaxis in Thai Population N/A